Matching-adjusted indirect comparison of benralizumab<i>versus</i>interleukin-5 inhibitors for the treatment of severe asthma: a systematic review
Crossref DOI link: https://doi.org/10.1183/13993003.01393-2018
Published Online: 2018-10-11
Published Print: 2018-11
Update policy: https://doi.org/10.1183/ers-crossmark-policy
Bourdin, Arnaud
Husereau, Don
Molinari, Nicolas
Golam, Sarowar
Siddiqui, Mohd Kashif
Lindner, Leandro
Xu, Xiao
Funding for this research was provided by:
AstraZeneca
